Brinzolamide Brimonidine Tartrate

Drug Index

Brinzolamide (trade names Azopt, Alcon Laboratories, Befardin,[2] Fardi Medicals,[3] ) is a carbonic anhydrase inhibitor used to lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Brinzolamide was approved as a generic medication in the United States in November 2020.[4] Contents 1 Chemistry 2 Indications 3 Pharmacodynamics 4 Pharmacokinetics 4.1 Absorption 4.2 Distribution 4.3 Metabolism 4.4 Excretion 5...

NDC Database

Simbrinza Ophthalmic Suspension/ Drops by Alcon Laboratories, Inc. ## Package Codes: 0065-4147-25, 0065-4147-27 ## Active Ingredients: Brimonidine Tartrate + Brinzolamide

NDC Database

Simbrinza Ophthalmic Suspension/ Drops by Novartis Pharmaceuticals Corporation ## Package Codes: 0078-0904-38, 0078-0904-98 ## Active Ingredients: Brinzolamide + Brimonidine Tartrate